Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

378 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Phenotypes of allo- and autoimmune antibody responses to FVIII characterized by surface plasmon resonance.
Lewis KB, Hughes RJ, Epstein MS, Josephson NC, Kempton CL, Kessler CM, Key NS, Howard TE, Kruse-Jarres R, Lusher JM, Walsh CE, Watts RG, Ettinger RA, Pratt KP; PATH (Personalized Alternative Therapies for Haemophilia) Study Investigators. Lewis KB, et al. PLoS One. 2013 May 8;8(5):e61120. doi: 10.1371/journal.pone.0061120. Print 2013. PLoS One. 2013. PMID: 23667433 Free PMC article.
Fundamentals for a Systematic Approach to Mild and Moderate Inherited Bleeding Disorders: An EHA Consensus Report.
Rodeghiero F, Pabinger I, Ragni M, Abdul-Kadir R, Berntorp E, Blanchette V, Bodó I, Casini A, Gresele P, Lassila R, Leebeek F, Lillicrap D, Mezzano D, Noris P, Srivastava A, Tosetto A, Windyga J, Zieger B, Makris M, Key N. Rodeghiero F, et al. Among authors: key n. Hemasphere. 2019 Sep 17;3(4):e286. doi: 10.1097/HS9.0000000000000286. eCollection 2019 Oct. Hemasphere. 2019. PMID: 31942541 Free PMC article. Review.
Prophylaxis in severe forms of von Willebrand's disease: results from the von Willebrand Disease Prophylaxis Network (VWD PN).
Abshire TC, Federici AB, Alvárez MT, Bowen J, Carcao MD, Cox Gill J, Key NS, Kouides PA, Kurnik K, Lail AE, Leebeek FW, Makris M, Mannucci PM, Winikoff R, Berntorp E; VWD PN. Abshire TC, et al. Among authors: key ns. Haemophilia. 2013 Jan;19(1):76-81. doi: 10.1111/j.1365-2516.2012.02916.x. Epub 2012 Jul 23. Haemophilia. 2013. PMID: 22823000 Free PMC article.
Microparticles in thrombosis and hemostasis.
Key NS, Kwaan HC. Key NS, et al. Semin Thromb Hemost. 2010 Nov;36(8):805-6. doi: 10.1055/s-0030-1267033. Epub 2010 Nov 3. Semin Thromb Hemost. 2010. PMID: 21049380 No abstract available.
Coagulation inhibition for sepsis.
Key NS, Ely EW. Key NS, et al. Curr Opin Hematol. 2002 Sep;9(5):416-21. doi: 10.1097/00062752-200209000-00005. Curr Opin Hematol. 2002. PMID: 12172460 Review.
Human coagulation factor FVIIa (recombinant) in the management of limb-threatening bleeds unresponsive to alternative therapies: results from the NovoSeven emergency-use programme in patients with severe haemophilia or with acquired inhibitors.
Arkin S, Blei F, Fetten J, Foulke R, Gilchrist GS, Heisel MA, Key N, Kisker CT, Kitchen C, Shafer FE, Shah PC, Strickland D. Arkin S, et al. Among authors: key n. Blood Coagul Fibrinolysis. 2000 Apr;11(3):255-9. Blood Coagul Fibrinolysis. 2000. PMID: 10870806 Clinical Trial.
Septic arthritis in males with haemophilia.
Ashrani AA, Key NS, Soucie JM, Duffy N, Forsyth A, Geraghty S; Universal Data Collection Project Investigators. Ashrani AA, et al. Among authors: key ns. Haemophilia. 2008 May;14(3):494-503. doi: 10.1111/j.1365-2516.2008.01662.x. Epub 2008 Feb 21. Haemophilia. 2008. PMID: 18298584 Free PMC article.
378 results